A physiologically based pharmacokinetic model of alvespimycin in mice and extrapolation to rats and humans
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A physiologically based pharmacokinetic model of alvespimycin in mice and extrapolation to rats and humans
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 171, Issue 11, Pages 2778-2789
Publisher
Wiley
Online
2014-01-29
DOI
10.1111/bph.12609
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery and development of heat shock protein 90 inhibitors as anticancer agents: a review of patented potent geldanamycin derivatives
- (2013) TaeHun Kim et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Physiologically based pharmacokinetic model of lapatinib developed in mice and scaled to humans
- (2013) Susan F. Hudachek et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- A Physiologically Based Pharmacokinetic Model for Strontium Exposure in Rat
- (2013) Henry Pertinez et al. PHARMACEUTICAL RESEARCH
- Targeting the molecular chaperone heat shock protein 90 (HSP90): Lessons learned and future directions
- (2012) David S. Hong et al. CANCER TREATMENT REVIEWS
- A Phase I Dose-Escalation Trial of Trastuzumab and Alvespimycin Hydrochloride (KOS-1022; 17 DMAG) in the Treatment of Advanced Solid Tumors
- (2012) K. Jhaveri et al. CLINICAL CANCER RESEARCH
- Molecular Pathways: Targeting Hsp90--Who Benefits and Who Does Not
- (2012) M. Scaltriti et al. CLINICAL CANCER RESEARCH
- Physiologically Based Pharmacokinetics Joined With In Vitro–In Vivo Extrapolation of ADME: A Marriage Under the Arch of Systems Pharmacology
- (2012) A Rostami-Hodjegan CLINICAL PHARMACOLOGY & THERAPEUTICS
- Physiologically Based Pharmacokinetic (PBPK) Modeling in Children
- (2012) J S Barrett et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Physiologically Based Pharmacokinetic Model of Amphotericin B Disposition in Rats Following Administration of Deoxycholate Formulation (Fungizone®): Pooled Analysis of Published Data
- (2011) Leonid Kagan et al. AAPS Journal
- A Phase I Study of the Heat Shock Protein 90 Inhibitor Alvespimycin (17-DMAG) Given Intravenously to Patients with Advanced Solid Tumors
- (2011) Simon Pacey et al. CLINICAL CANCER RESEARCH
- Physiologically Based Pharmacokinetic Modeling: Methodology, Applications, and Limitations with a Focus on Its Role in Pediatric Drug Development
- (2011) Feras Khalil et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Applications of Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation During Regulatory Review
- (2010) P Zhao et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- In Vitro Metabolism of 17-(Dimethylaminoethylamino)-17-demethoxygeldanamycin in Human Liver Microsomes
- (2010) N. Zheng et al. DRUG METABOLISM AND DISPOSITION
- Phase I Pharmacokinetic and Pharmacodynamic Study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an Inhibitor of Heat-Shock Protein 90, in Patients With Advanced Solid Tumors
- (2010) Ramesh K. Ramanathan et al. JOURNAL OF CLINICAL ONCOLOGY
- The Role of Lysosomes in Limiting Drug Toxicity in Mice
- (2010) R. A. Ndolo et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia
- (2010) J E Lancet et al. LEUKEMIA
- The Average Body Surface Area of Adult Cancer Patients in the UK: A Multicentre Retrospective Study
- (2010) Joseph J. Sacco et al. PLoS One
- Physiologically Based Pharmacokinetic Modeling of Deltamethrin: Development of a Rat and Human Diffusion-Limited Model
- (2010) Stephen J. Godin et al. TOXICOLOGICAL SCIENCES
- To scale or not to scale: the principles of dose extrapolation
- (2009) Vijay Sharma et al. BRITISH JOURNAL OF PHARMACOLOGY
- Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies
- (2009) Shivaani Kummar et al. EUROPEAN JOURNAL OF CANCER
- Heat Shock Protein 90 as a Drug Target: Some Like It Hot
- (2008) U. Banerji CLINICAL CANCER RESEARCH
- Enzymatic Reduction and Glutathione Conjugation of Benzoquinone Ansamycin Heat Shock Protein 90 Inhibitors: Relevance for Toxicity and Mechanism of Action
- (2008) W. Guo et al. DRUG METABOLISM AND DISPOSITION
- Whole body physiologically-based pharmacokinetic models: their use in clinical drug development
- (2008) Andrea N Edginton et al. Expert Opinion on Drug Metabolism & Toxicology
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started